Severe reactivation of seronegative occult hepatitis B after chemotherapy for lymphoma

Lancet. 2024 Apr 6;403(10434):1372-1373. doi: 10.1016/S0140-6736(24)00397-0.

¹ Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: htorres@mdanderson.org.
² Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

MeSH terms